These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38548435)

  • 1. Hepatic Encephalopathy-A Guide to Laboratory Testing.
    Lee F; Frederick RT
    Clin Liver Dis; 2024 May; 28(2):225-236. PubMed ID: 38548435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends.
    Deutsch-Link S; Moon AM; Jiang Y; Barritt AS; Tapper EB
    Clin Ther; 2022 Mar; 44(3):e45-e57. PubMed ID: 35125217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ammonia Levels and Hepatic Encephalopathy in Patients with Known Chronic Liver Disease.
    Ninan J; Feldman L
    J Hosp Med; 2017 Aug; 12(8):659-661. PubMed ID: 28786433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Helicobacter pylori infection in hyperammonemia and subclinical hepatic encephalopathy in cirrhosis of liver.
    Kini D; Aggarwal R; Saraswat VA; Naik SR
    Indian J Gastroenterol; 2001; 20(6):237-40. PubMed ID: 11817778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why and when to measure ammonemia in cirrhosis?
    Mallet M; Weiss N; Thabut D; Rudler M
    Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):505-511. PubMed ID: 29551609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.
    Iwasa M; Sugimoto R; Mifuji-Moroka R; Hara N; Yoshikawa K; Tanaka H; Eguchi A; Yamamoto N; Sugimoto K; Kobayashi Y; Hasegawa H; Takei Y
    Metab Brain Dis; 2016 Oct; 31(5):1151-6. PubMed ID: 27353278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism.
    Díaz-Fontenla F; Castillo-Pradillo M; Díaz-Gómez A; Ibañez-Samaniego L; Gancedo P; Guzmán-de-Villoria JA; Fernández-García P; Bañares-Cañizares R; García-Martínez R
    World J Gastroenterol; 2017 Jul; 23(28):5246-5252. PubMed ID: 28811719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of ammonia and blood laboratory parameters with hepatic encephalopathy: A systematic review and meta-analysis.
    Sepehrinezhad A; Moghaddam NG; Shayan N; Sahab Negah S
    PLoS One; 2024; 19(9):e0307899. PubMed ID: 39226259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of Helicobacter pylori in liver cirrhosis complicated with hepatic encephalopathy].
    Săndulache L; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1056-60. PubMed ID: 20191873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breath and blood ammonia in liver cirrhosis.
    Shimamoto C; Hirata I; Katsu K
    Hepatogastroenterology; 2000; 47(32):443-5. PubMed ID: 10791209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ongoing Debate of Serum Ammonia Levels in Cirrhosis: the Good, the Bad, and the Ugly.
    Deutsch-Link S; Moon AM
    Am J Gastroenterol; 2023 Jan; 118(1):10-13. PubMed ID: 36001400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of Ammonia as a Biomarker in Patients with Cirrhosis.
    Ballester MP; Durmazer EN; Qi T; Jalan R
    Semin Liver Dis; 2024 Aug; 44(3):356-368. PubMed ID: 39095029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
    Tapper EB; Jiang ZG; Patwardhan VR
    Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current approaches to hepatic encephalopathy.
    Vidal-Cevallos P; Chávez-Tapia NC; Uribe M
    Ann Hepatol; 2022; 27(6):100757. PubMed ID: 36115576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Blinded Assessment of Ammonia Testing Demonstrates Low Utility Among Front-Line Clinicians.
    Gonzalez JJ; Tapper EB
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e895-e896. PubMed ID: 33453401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.